New developments were reported Wednesday across relevant sectors.
A pill-form GLP-1 drug showed impressive results in a large trial, improving glucose levels and enabling significant weight loss in people with type 2 diabetes.
These developments come amid broader ongoing trends in the sector, with stakeholders monitoring the situation as events continue to unfold.
Further updates are expected as more information becomes available from relevant sources.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://www.sciencedaily.com/